The articles listed on this page are from a variety of sources. 
1. The staff of DBS-STN often attends conferences or educational opportunities both nationally and internationally, and a brief understandable write-up of the information presented at the event will be provided for our readers to review. 
2. DBS-STN staff also identifies or writes various articles related to topics that are thought to be of interest for the reader of www.DBS-STN.org. 

Browse by Topic:
Search:

US WorldMeds Launches Final Phase III Trial to Study Myobloc Injections to Treat Drooling


(November 20, 2013) - US WorldMeds, LLC, has launched a final phase III clinical trial to investigate the use of Myobloc (rimabotulinumtoxinB) injection to treat sialorrhea, commonly known as “drooling.” This “drooling” is common in patients who may have difficulty swallowing due to neurological disorders such as Parkinson’s disease, Lou Gehrig’s disease, stroke, brain injury, and cerebral palsy. Read more…



Article Archive

back